These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10475607)

  • 1. Immunosuppressory mini-regions of HLA-DP and HLA-DR.
    Szewczuk Z; Wilczyński A; Stefanowicz P; Fedorowicz W; Siemion IZ; Wieczorek Z
    Mol Immunol; 1999 Jun; 36(8):525-33. PubMed ID: 10475607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunosuppressory and adhesive miniregion of the human major histocompatibility protein, human leukocyte antigen DQ.
    Szewczuk Z; Stefanowicz P; Wilczyński A; Siemion IZ; Cierniewski CS; Kralisz U; Wieczorek Z
    Biopolymers; 1996; 40(5):571-83. PubMed ID: 9062075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological properties of the thymopentin-like fragments of HLA-DQ.
    Szewczuk Z; Siemion IZ; Wieczorek Z
    Mol Immunol; 1996 Aug; 33(11-12):903-8. PubMed ID: 8960113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressory activity of the cyclodimeric peptide with RGD-sequences.
    Szewczuk Z; Buczek P; Stefanowicz P; Krajewski K; Wieczorek Z; Siemion IZ
    Acta Biochim Pol; 2001; 48(1):121-30. PubMed ID: 11440161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimerization of the immunosuppressive peptide fragment of HLA-DR molecule enhances its potency.
    Szewczuk Z; Biernat M; Dyba M; Zimecki M
    Peptides; 2004 Feb; 25(2):207-15. PubMed ID: 15063002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further investigations on thymopentin-like fragments of HLA-DQ and their analogs.
    Szewczuk Z; Wieczorek Z; Stefanowicz P; Wilczyński A; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1997; 45(4):335-41. PubMed ID: 9523010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclodimerization of immunosuppressive fragment of HLA-DR molecule. Design, synthesis and ESI-MS/MS analysis.
    Biernat M; Cydzik M; Stefanowicz P; Kluczyk A; Artym J; Zimecki M; Szewczuk Z
    J Pept Sci; 2016 Aug; 22(8):525-32. PubMed ID: 27443978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New conformationally restricted analog of the immunosuppressory mini-domain of HLA-DQ and its biological properties.
    Szewczuk Z; Wilczyński A; Dyba M; Petry I; Siemion IZ; Wieczorek Z
    Peptides; 2000 Dec; 21(12):1849-58. PubMed ID: 11150645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressory activity of ubiquitin fragments containing retro-RGD sequence.
    Szewczuk Z; Stefanowicz P; Wilczyński A; Staszewska A; Siemion IZ; Zimecki M; Wieczorek Z
    Biopolymers; 2004 Aug; 74(5):352-62. PubMed ID: 15222015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino-terminal dimerization of peptides on the solid support. Synthesis and biological activity of the immunosuppressive HLA-DR fragments linked by poly(ethylene glycol)s.
    Biernat M; Stefanowicz P; Zimecki M; Szewczuk Z
    Bioconjug Chem; 2006; 17(5):1116-24. PubMed ID: 16984118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive activity of alanine analogs of cyclolinopeptide A.
    Wieczorek Z; Zimecki M; Pedyczak A; Lisowski M; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):291-6. PubMed ID: 8010868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segregation of HLA-DR, -DQ and -DP phenotypes and restriction fragment length polymorphic fragments in two recombinant families.
    Munck Petersen C; Juncker Sørensen I; Hyldig-Nielsen JJ; Lamm LU
    Tissue Antigens; 1988 Aug; 32(2):104-11. PubMed ID: 2904184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunosuppressive mini-domain of human lactoferrin.
    Siemion IZ; Sloń J; Wieczorek Z
    J Pept Sci; 1995; 1(5):295-302. PubMed ID: 9223008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DQ7 beta(1) and beta(2) derived peptides as immunomodulators.
    Skarlas T; Panou-Pomonis E; Kluczyk A; Szewczuk Z; Zimecki M; Kosmopoulou A; Sakarellos-Daitsiotis M; Sakarellos C
    J Pept Sci; 2009 Apr; 15(4):296-304. PubMed ID: 19206073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitopes of HLA-A, B, C, DR, DQ, DP and MICA antigens.
    El-Awar N; Terasaki PI; Cai J; Deng CT; Ozawa M; Nguyen A; Lias M; Conger N
    Clin Transpl; 2009; ():295-321. PubMed ID: 20524293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Threonine at position 6 is not essential for the immunosuppressive activity of HLA-DQ(beta164-172)-hexapeptide.
    Stefanowicz P; Boratyński PJ; Staszewska A; Wilczyński A; Zimecki M; Szewczuk Z
    Mol Immunol; 2004 Jul; 41(9):911-7. PubMed ID: 15261463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
    Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
    J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No association with HLA-DR, -DQ or -DP alleles in Guillain-Barré syndrome.
    Hillert J; Osterman PO; Olerup O
    J Neuroimmunol; 1991 Jan; 31(1):67-72. PubMed ID: 1984036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
    Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
    J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel immunosuppressory peptide originating from the ubiquitin sequence.
    Pasikowski P; Goździewicz T; Stefanowicz P; Artym J; Zimecki M; Szewczuk Z
    Peptides; 2011 Dec; 32(12):2418-27. PubMed ID: 22008734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.